Pfizer continues to stalk AstraZeneca, even as other firms abandon mega mergers.
-
Join 34 other subscribers
Categories
Top Posts
Blogroll
Undeterred, Pfizer continues its mega merger strategy
Pfizer continues to stalk AstraZeneca, even as other firms abandon mega mergers.
This entry was posted in Pharmaceutical Industry and tagged AstraZeneca, mergers, Pfizer. Bookmark the permalink.
MechanizedIntelligence 